Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

340.02 +2.53 (+0.75%)

Streaming Delayed Price Updated: 3:42 PM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

61 62 Next >

The 3 Best Healthcare Stocks to Buy in July 2024 ↗

July 04, 2024

Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.

Via InvestorPlace

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead ↗

July 04, 2024

Eli Lilly is a good stock to buy, but these should be even better.

Via The Motley Fool

S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday? ↗

July 03, 2024

The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...

Via Benzinga

Topics Economy Stocks

What the Options Market Tells Us About Amgen ↗

July 02, 2024

Via Benzinga

Amgen Unusual Options Activity ↗

July 01, 2024

Via Benzinga

Can Amgen Stock Keep Trouncing the S&P 500? ↗

June 27, 2024

Amgen's market-beating ways are unlikely to evaporate any time soon.

Via The Motley Fool

Topics Stocks

Smart Money Is Betting Big In AMGN Options ↗

June 25, 2024

Via Benzinga

Where Will Amgen Be in 5 Years? ↗

June 20, 2024

Can Amgen be a market-beating stock?

Via The Motley Fool

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

1 Dividend Growth Stock to Buy and Hold for 10 Years ↗

June 29, 2024

This company's payouts look safe.

Via The Motley Fool

10 Blue-Chip Dividend Growth Stocks With 3% Yields And Safe Dividends ↗

June 28, 2024

A look at 10 blue-chip dividend growth stocks with yields above 3%, the opportunity for those yields to continue growing in the future, and where we can be very certain that the dividend is safe.

Via Talk Markets

These Are The Best Dow Jones Stocks Of 2024 Thus Far ↗

June 27, 2024

The AI boom helped to produce two best Dow Jones stocks, including newbie Amazon.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

Check Out What Whales Are Doing With AMGN ↗

June 18, 2024

Via Benzinga

Expert Ratings For Amgen ↗

June 14, 2024

Via Benzinga

Decoding Amgen's Options Activity: What's the Big Picture? ↗

June 12, 2024

Via Benzinga

Tech Is Consolidating And The Market’s Seeking New Leadership ↗

June 25, 2024

The tape tells the tale, just like it always does: The tech sector is clearly in consolidation mode right now.

Via Talk Markets

10 Health Care Stocks Whale Activity In Today's Session ↗

June 24, 2024

Via Benzinga

Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments ↗

June 21, 2024

Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.

Via Benzinga

Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

June 20, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

Via FinancialNewsMedia

Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

June 20, 2024

From FN Media Group LLC

Via GlobeNewswire

7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline ↗

June 17, 2024

With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities.

Via InvestorPlace

Market Whales and Their Recent Bets on AMGN Options ↗

June 06, 2024

Via Benzinga

Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines

June 17, 2024

Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA

Via MarketBeat

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks ↗

June 13, 2024

The companies are closing in on the finish line for two new COPD treatments.

Via Investor's Business Daily

3 Stocks to Buy as Ozempic Surges in Popularity ↗

June 13, 2024

Ozempic has surged in popularity in recent years, but the best may be to come as innovators look to launch new drugs to meet hot demand.

Via InvestorPlace

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club ↗

June 12, 2024

Enthusiasm is growing for a looming approval in COPD treatment.

Via Investor's Business Daily

Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet ↗

June 10, 2024

The company is focusing on obesity treatment after its glaucoma drug failed.

Via Investor's Business Daily

Is Geron Stock a Buy Following Its First New Drug Approval? ↗

June 08, 2024

Find out if the high-flying biotech stock can keep on climbing higher.

Via The Motley Fool

Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal ↗

June 05, 2024

Amgen announced Phase 3 trial results for Uplizna for IgG4-related disease, achieving an 87% reduction in flare risk. All key secondary endpoints were met with no new safety signals.

Via Benzinga

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy. ↗

June 03, 2024

There's probably a big enough pie here for everyone to get a slice.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.